MOLINA HEALTHCARE INC (MOH) Fundamental Analysis & Valuation
NYSE:MOH • US60855R1005
Current stock price
146.49 USD
-2.71 (-1.82%)
At close:
146.49 USD
0 (0%)
After Hours:
This MOH fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. MOH Profitability Analysis
1.1 Basic Checks
- MOH had positive earnings in the past year.
- In the past year MOH has reported a negative cash flow from operations.
- MOH had positive earnings in each of the past 5 years.
- MOH had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
- MOH's Return On Assets of 3.03% is fine compared to the rest of the industry. MOH outperforms 65.35% of its industry peers.
- MOH's Return On Equity of 11.60% is fine compared to the rest of the industry. MOH outperforms 78.22% of its industry peers.
- MOH has a Return On Invested Capital of 7.39%. This is in the better half of the industry: MOH outperforms 70.30% of its industry peers.
- MOH had an Average Return On Invested Capital over the past 3 years of 14.32%. This is significantly above the industry average of 8.92%.
- The 3 year average ROIC (14.32%) for MOH is well above the current ROIC(7.39%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.03% | ||
| ROE | 11.6% | ||
| ROIC | 7.39% |
ROA(3y)5.97%
ROA(5y)5.95%
ROE(3y)21.24%
ROE(5y)23.1%
ROIC(3y)14.32%
ROIC(5y)15.99%
1.3 Margins
- MOH has a Profit Margin of 1.04%. This is comparable to the rest of the industry: MOH outperforms 57.43% of its industry peers.
- MOH's Profit Margin has declined in the last couple of years.
- MOH has a Operating Margin (1.73%) which is in line with its industry peers.
- In the last couple of years the Operating Margin of MOH has declined.
- Looking at the Gross Margin, with a value of 13.07%, MOH is doing worse than 67.33% of the companies in the same industry.
- In the last couple of years the Gross Margin of MOH has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 1.73% | ||
| PM (TTM) | 1.04% | ||
| GM | 13.07% |
OM growth 3Y-27.35%
OM growth 5Y-21.51%
PM growth 3Y-25.14%
PM growth 5Y-21.41%
GM growth 3Y-4.5%
GM growth 5Y-6.76%
2. MOH Health Analysis
2.1 Basic Checks
- MOH has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
- Compared to 1 year ago, MOH has less shares outstanding
- MOH has less shares outstanding than it did 5 years ago.
- MOH has a worse debt/assets ratio than last year.
2.2 Solvency
- MOH has an Altman-Z score of 4.19. This indicates that MOH is financially healthy and has little risk of bankruptcy at the moment.
- MOH has a Altman-Z score of 4.19. This is in the better half of the industry: MOH outperforms 78.22% of its industry peers.
- A Debt/Equity ratio of 0.97 indicates that MOH is somewhat dependend on debt financing.
- The Debt to Equity ratio of MOH (0.97) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.97 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 4.19 |
ROIC/WACC0.92
WACC7.99%
2.3 Liquidity
- A Current Ratio of 1.69 indicates that MOH should not have too much problems paying its short term obligations.
- MOH has a Current ratio of 1.69. This is in the better half of the industry: MOH outperforms 68.32% of its industry peers.
- MOH has a Quick Ratio of 1.69. This is a normal value and indicates that MOH is financially healthy and should not expect problems in meeting its short term obligations.
- The Quick ratio of MOH (1.69) is better than 70.30% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.69 | ||
| Quick Ratio | 1.69 |
3. MOH Growth Analysis
3.1 Past
- MOH shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -52.98%.
- MOH shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -0.02% yearly.
- Looking at the last year, MOH shows a quite strong growth in Revenue. The Revenue has grown by 11.75% in the last year.
- Measured over the past years, MOH shows a quite strong growth in Revenue. The Revenue has been growing by 18.52% on average per year.
EPS 1Y (TTM)-52.98%
EPS 3Y-15.91%
EPS 5Y-0.02%
EPS Q2Q%-154.46%
Revenue 1Y (TTM)11.75%
Revenue growth 3Y12.42%
Revenue growth 5Y18.52%
Sales Q2Q%8.34%
3.2 Future
- The Earnings Per Share is expected to grow by 21.69% on average over the next years. This is a very strong growth
- Based on estimates for the next years, MOH will show a small growth in Revenue. The Revenue will grow by 4.17% on average per year.
EPS Next Y-26.98%
EPS Next 2Y1.58%
EPS Next 3Y13.62%
EPS Next 5Y21.69%
Revenue Next Year0%
Revenue Next 2Y3.1%
Revenue Next 3Y3.89%
Revenue Next 5Y4.17%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. MOH Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 13.75, which indicates a correct valuation of MOH.
- Compared to the rest of the industry, the Price/Earnings ratio of MOH indicates a rather cheap valuation: MOH is cheaper than 85.15% of the companies listed in the same industry.
- When comparing the Price/Earnings ratio of MOH to the average of the S&P500 Index (25.96), we can say MOH is valued slightly cheaper.
- A Price/Forward Earnings ratio of 18.84 indicates a rather expensive valuation of MOH.
- MOH's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. MOH is cheaper than 61.39% of the companies in the same industry.
- Compared to an average S&P500 Price/Forward Earnings ratio of 24.04, MOH is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.75 | ||
| Fwd PE | 18.84 |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | -0.79 |
4.3 Compensation for Growth
- A more expensive valuation may be justified as MOH's earnings are expected to grow with 13.62% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y1.58%
EPS Next 3Y13.62%
5. MOH Dividend Analysis
5.1 Amount
- MOH does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
MOH Fundamentals: All Metrics, Ratios and Statistics
146.49
-2.71 (-1.82%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-05 2026-02-05/amc
Earnings (Next)04-22 2026-04-22/amc
Inst Owners105.33%
Inst Owner Change-7.91%
Ins Owners1.33%
Ins Owner Change10.61%
Market Cap7.54B
Revenue(TTM)45.43B
Net Income(TTM)472.00M
Analysts65
Price Target156.67 (6.95%)
Short Float %6.99%
Short Ratio1.99
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-484.67%
Min EPS beat(2)-916.01%
Max EPS beat(2)-53.34%
EPS beat(4)1
Avg EPS beat(4)-243.64%
Min EPS beat(4)-916.01%
Max EPS beat(4)1.06%
EPS beat(8)4
Avg EPS beat(8)-122.21%
EPS beat(12)7
Avg EPS beat(12)-79.46%
EPS beat(16)11
Avg EPS beat(16)-58.81%
Revenue beat(2)2
Avg Revenue beat(2)3.86%
Min Revenue beat(2)3.74%
Max Revenue beat(2)3.99%
Revenue beat(4)4
Avg Revenue beat(4)3.29%
Min Revenue beat(4)2.13%
Max Revenue beat(4)3.99%
Revenue beat(8)8
Avg Revenue beat(8)2.71%
Revenue beat(12)10
Avg Revenue beat(12)2.28%
Revenue beat(16)14
Avg Revenue beat(16)2.34%
PT rev (1m)-12.12%
PT rev (3m)-10.16%
EPS NQ rev (1m)-29.32%
EPS NQ rev (3m)-38.77%
EPS NY rev (1m)-44.06%
EPS NY rev (3m)-42.68%
Revenue NQ rev (1m)-1.94%
Revenue NQ rev (3m)-5.23%
Revenue NY rev (1m)-4%
Revenue NY rev (3m)-4.35%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.75 | ||
| Fwd PE | 18.84 | ||
| P/S | 0.17 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 1.85 | ||
| P/tB | 4.03 | ||
| EV/EBITDA | -0.79 |
EPS(TTM)10.65
EY7.27%
EPS(NY)7.78
Fwd EY5.31%
FCF(TTM)-12.35
FCFYN/A
OCF(TTM)-10.39
OCFYN/A
SpS882.06
BVpS79.01
TBVpS36.39
PEG (NY)N/A
PEG (5Y)N/A
Graham Number137.6
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.03% | ||
| ROE | 11.6% | ||
| ROCE | 9.57% | ||
| ROIC | 7.39% | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | 1.73% | ||
| PM (TTM) | 1.04% | ||
| GM | 13.07% | ||
| FCFM | N/A |
ROA(3y)5.97%
ROA(5y)5.95%
ROE(3y)21.24%
ROE(5y)23.1%
ROIC(3y)14.32%
ROIC(5y)15.99%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)18.55%
ROCE(5y)20.72%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-27.35%
OM growth 5Y-21.51%
PM growth 3Y-25.14%
PM growth 5Y-21.41%
GM growth 3Y-4.5%
GM growth 5Y-6.76%
F-Score4
Asset Turnover2.92
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.97 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 4.03 | ||
| Cap/Depr | 51.79% | ||
| Cap/Sales | 0.22% | ||
| Interest Coverage | 4.33 | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.69 | ||
| Quick Ratio | 1.69 | ||
| Altman-Z | 4.19 |
F-Score4
WACC7.99%
ROIC/WACC0.92
Cap/Depr(3y)51.56%
Cap/Depr(5y)53.03%
Cap/Sales(3y)0.24%
Cap/Sales(5y)0.26%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-52.98%
EPS 3Y-15.91%
EPS 5Y-0.02%
EPS Q2Q%-154.46%
EPS Next Y-26.98%
EPS Next 2Y1.58%
EPS Next 3Y13.62%
EPS Next 5Y21.69%
Revenue 1Y (TTM)11.75%
Revenue growth 3Y12.42%
Revenue growth 5Y18.52%
Sales Q2Q%8.34%
Revenue Next Year0%
Revenue Next 2Y3.1%
Revenue Next 3Y3.89%
Revenue Next 5Y4.17%
EBIT growth 1Y-54.1%
EBIT growth 3Y-18.33%
EBIT growth 5Y-6.97%
EBIT Next Year-29.1%
EBIT Next 3Y6.7%
EBIT Next 5Y18.96%
FCF growth 1Y-216.91%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-183.07%
OCF growth 3YN/A
OCF growth 5YN/A
MOLINA HEALTHCARE INC / MOH Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for MOLINA HEALTHCARE INC?
ChartMill assigns a fundamental rating of 4 / 10 to MOH.
What is the valuation status of MOLINA HEALTHCARE INC (MOH) stock?
ChartMill assigns a valuation rating of 3 / 10 to MOLINA HEALTHCARE INC (MOH). This can be considered as Overvalued.
How profitable is MOLINA HEALTHCARE INC (MOH) stock?
MOLINA HEALTHCARE INC (MOH) has a profitability rating of 5 / 10.
Can you provide the PE and PB ratios for MOH stock?
The Price/Earnings (PE) ratio for MOLINA HEALTHCARE INC (MOH) is 13.75 and the Price/Book (PB) ratio is 1.85.